—SO
— • —
$95.79
P/E
24.46
PEG
—
FCF Yield
—
Rev Growth YoY
+1055.0% YoY
Gross Margin
4003.5%
Health Score
4/10
D/E Ratio
2.02
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this data payload, making it impossible to describe the specific company or its industry. What can be confirmed is that this is a company currently trading at $95.79 per share with a P/E ratio of 24.46x and a Price/Sales ratio of 3.85x. Without market capitalisation data, the cap tier cannot be formally assigned, though the financial profile — including elevated leverage and a high return on equity — is consistent with a small-to-mid cap operator.
Financial Health
**Score: 4/10** The financial health picture is deeply contradictory. On the surface, a gross margin of 4,003.5% and a net margin of 1,536.0% appear extraordinary, but figures of this magnitude almost certainly reflect a very small or distorted revenue base that inflates percentage ratios to economically implausible levels, severely limiting their interpretive value...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 4,003.5% and net margin of 1,536.0% are economically implausible and suggest the revenue base may be near-zero or the data is distorted, making financial analysis unreliable. - **EARNINGS DETERIORATION:** Earnings growth of -194.0% YoY means the company moved from profit to loss (or deepened losses) even during a period of extreme revenue growth. - **LIQUIDITY:** Current ratio of 0.65x indicates current liabilities exceed current assets, posing a near-term solvency risk. - **LEVERAGE:** Debt/equity of 2.02x is elevated, and with free cash flow unavailable, the company's ability to service this debt cannot be verified. - **EARNINGS QUALITY:** The company beat earnings estimates in only 1 of the last 4 quarters, and no quarterly financial detail is available to assess trend consistency....